Echocardiography expert Patricia A. Pellikka, MD, discussed the trend of increasing artificial intelligence (AI) integration in cardiac ultrasound with Cardiovascular Business at American College of Cardiology (ACC) 2023 meeting.

AI's growing impact on echocardiography

Cardiology has the second largest number of FDA-cleared AI algorithms, and many of them are for cardiac ultrasound. Echocardiography expert Patricia A. Pellikka, MD, discusses this trend and how AI is helping improve echo.

Advanced imaging does not always improve outcomes, data suggest

Although advanced imaging exams have proven benefits in defining disease severity, new data indicate that more sophisticated studies might not impact outcomes as much as previously thought. 

A figure from the ASE pediatric POCUS guidelines showing parasternal short-axis view demonstrating RV dilatation with bowing of the septum into the left ventricle, indicating pulmonary hypertension in this child with shock and pertussis.

New ASE guidance examines cardiac POCUS in children

The recommendations were developed by a writing group comprised of experts from different specialties, offering an array of perspectives and approaches.

IVUS Intravascular Ultrasound ACC

ACC urges all interventional cardiologists to use intravascular imaging during PCI

New recommendations from the American College of Cardiology detail how intravascular imaging can help clinicians before, during and after PCI procedures. 

A CT coronary calcium scoring exam at Northwestern Medicine's Central DuPage Hospital in the Chicago Suburbs. Dave Fornell

The remaining gaps in evidence for cardiac CT

While the ACC/AHA 2021 Chest Pain Assessment Guidelines included cardiac CT angiography as a top level recommendation, gaps in evidence still need to be filled.

An example of an FDA cleared radiology AI algorithm to automatically take a cardiac CT scan and identify, contour and quantify soft plaque in the coronary arteries. The Cleerly software then generates an automated report with images, measurements and a risk assessment for the patient. This type of quantification is too time consuming and complex for human readers to bother with, but AI assisted reports like this may become a new normal over the next decade. Example from Cleerly Imaging at SCCT 2022.

Legal considerations for artificial intelligence in radiology and cardiology

There are now more than 520 FDA-cleared AI algorithms and the majority are for radiology and cardiology, raising the question of who is liable if the AI gets something wrong.

Increased use of CCTA improves CAD outcomes without raising costs

Researchers examined data from nearly 2 million patients, sharing their full findings in JACC: Cardiovascular Imaging.

A 3D echo of a rheumatic mitral valve and a 2D image of the same valve showing the irregularly shaped valve opening. Images are part of the figures in the new ASE guidelines.

ASE releases updated rheumatic heart disease guideline

The American Society of Echocardiography released a new guideline document on the comprehensive use of echocardiography in the diagnosis and therapeutic intervention of rheumatic heart disease.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.